← The Wire
PBYINasdaq
PUMA BIOTECHNOLOGY, INC.
Pharmaceutical Preparations · DE · CIK 1401667
Develops and commercializes innovative cancer treatments, currently marketing NERLYNX for HER2-positive breast cancer
$373M
Market cap
$8.19
Last close
+1.0%
1D
+6.9%
5D
345K
Volume
Price · last 39 sessions+8.8%
May 4L $6.81 · H $8.19Jun 29
328
Total filings
Jun 16, 2026
Last filing
12/31
Fiscal year end
DEFA14AFORM DEFA14AApr 28, 2026DEFA14AFORM DEFA14AApr 28, 2025DEFA14AFORM DEFA14AApr 26, 2024DEFA14AFORM DEFA14AApr 28, 2023DEFA14AFORM DEFA14AApr 29, 2022DEFA14ADEFA14AApr 26, 2021DEFA14ADEFA14AApr 27, 2020DEFA14ADEFA14AApr 29, 2019DEFA14ADEFA14AApr 30, 2018DEFA14ADEFA14AApr 28, 2017DEFA14ADEFA14AApr 29, 2016DEFA14ADEFA14AJan 27, 2016DEFA14ADEFA14AJan 8, 2016DEFA14ADEFA14AJan 7, 2016DEFA14ADEFA14ADec 30, 2015DEFA14ADEFA14ADec 29, 2015DEFA14ADEFA14ADec 23, 2015DEFA14ADEFA14ADec 4, 2015DEFA14A8-KNov 19, 2015DEFA14A8-KNov 2, 2015DEFA14ADEFA14AApr 30, 2015DEFA14ADEFA14AApr 30, 2014DEFA14ADEFA14AApr 30, 2013
Insider Activity
In the 90 days to Jan 7, 2026: 4 sold $419K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 7, 2026 | Auerbach Alan HPresident and CEO | Sell | 18,012 | $5.88 | $106K |
| Jan 7, 2026 | Nougues Maximo FChief Financial Officer | Sell | 6,405 | $5.88 | $38K |
| Jan 7, 2026 | Hunt Douglas MSee Remarks | Sell | 5,014 | $5.88 | $29K |
| Jan 6, 2026 | Auerbach Alan HPresident and CEO | Sell | 16,938 | $5.84 | $99K |
| Jan 6, 2026 | Nougues Maximo FChief Financial Officer | Sell | 4,540 | $5.84 | $27K |
| Jan 6, 2026 | Hunt Douglas MSee Remarks | Sell | 3,973 | $5.84 | $23K |
| Nov 11, 2025 | Miller Michael PatrickDirector | Sell | 20,000 | $4.86 | $97K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance